Clinical Trial Update: A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Clofarabine for older patients with newly diagnosed acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Myelogenous Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-03-24